Detalhe da pesquisa
1.
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study.
Am J Hematol
; 97(9): 1189-1199, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731907
2.
Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis.
Eur J Haematol
; 105(4): 495-501, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564450
3.
Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes.
Haematologica
; 108(6): 1680-1684, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546447
4.
Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre.
Amyloid
; 30(3): 297-302, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718932
5.
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis.
Blood Adv
; 7(20): 6080-6091, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581513
6.
Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis.
Kidney Med
; 4(4): 100427, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35342879
7.
Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.
Am J Cardiol
; 181: 105-112, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028388
8.
A novel substitution of proline (P32L) destabilises ß2-microglobulin inducing hereditary systemic amyloidosis.
Amyloid
; 29(4): 255-262, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575118
9.
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.
Blood Cancer J
; 11(8): 139, 2021 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34349108